Patents Examined by Trent Clarke
-
Patent number: 9404076Abstract: A dry yeast composition which includes 5-adenosyl-L-methionine and a thickener and has excellent storage stability. A thickener is added to a yeast cell concentrate obtained by culturing yeast which has SAMe-producing ability and collecting the cells, and the resultant mixture is dried. Thus, a dry yeast containing a high concentration of 5-adenosyl-L-methionine which has excellent storage stability and excellent bioabsorbability can be easily and profitably produced. It is hence possible to supply a market with a dry yeast composition that contains a high concentration of 5-adenosyl-L-methionine, which is useful as a water-soluble physiologically active substance, and that has excellent storage stability and bioabsorbability.Type: GrantFiled: April 5, 2011Date of Patent: August 2, 2016Assignee: MITSUBISHI GAS CHEMICAL COMPANY, INC.Inventors: Kentarou Takano, Shinyo Gayama
-
Patent number: 9400274Abstract: In general, the present invention relates to identification of lipidome biomarkers for cancer analysis and it provides prognostic and predictive methods and kits for cancer diagnosis and subtyping and for diagnosing and/or predicting the evolution of a tumor and its response to lipid metabolism-targeted or other types of therapy in a subject, by making use of phospholipid (PL) profiling, wherein changes in the combined acyl chain length of intact body fluid-derived or tumor-derived phospholipid species is indicative of an elongation phenotype.Type: GrantFiled: March 25, 2013Date of Patent: July 26, 2016Assignee: KATHOLIEKE UNIVERSITEIT LEUVENInventors: Johannes Victor Maria Swinnen, Jelle Machiels, Eyra Marie-Jeanne Edel Leopold Marien, Muralidhara Rao Bagadi
-
Patent number: 9358255Abstract: The invention is directed to a method for isolating stromal cells to form a therapeutic composition; and administering said therapeutic composition to the subject. A further embodiment of the invention is directed to therapeutic compositions comprising isolated stromal cells.Type: GrantFiled: October 8, 2013Date of Patent: June 7, 2016Assignee: SpineSmith Partners, L.P.Inventors: Kevin Dunworth, Richard J. Kana, Theodore Sand, Matthew Murphy
-
Patent number: 9340476Abstract: This specification discloses an operational continuous process to convert lignin as found in ligno-cellulosic biomass before or after converting at least some of the carbohydrates. The continuous process has been demonstrated to create a slurry comprised of lignin, raise the slurry comprised of lignin to ultra-high pressure, deoxygenate the lignin in a lignin conversion reactor over a catalyst which is not a fixed bed without producing char. The conversion products of the carbohydrates or lignin can be further processed into polyester intermediates for use in polyester preforms and bottles.Type: GrantFiled: February 24, 2013Date of Patent: May 17, 2016Assignee: Biochemtex S.p.A.Inventors: Guliz Arf Elliott, Dan Gastaldo, Aaron Murray, Steven Ryba
-
Patent number: 9291533Abstract: The present invention relates to a method for processing isolated cells, in particular rare cells such as circulating tumor cells, to render them suitable for optical imaging, comprising the steps of (a) depositing filter material comprising captured cells on a phase-change medium; (b) melting said phase-change medium until the medium is spread out below said filter material; and (c) lowering the temperature of said phase-change medium until the medium solidifies, resulting in an optically flat filter comprising said cells at a fixed position. The method may additionally comprise an initial step of capturing a cell on a filter material. The phase-change medium, preferably paraffin wax, may comprise a porous, or mesh-like structure allowing the passage of a fluid through the medium. The phase-change medium may further be mounted on a carrier such as a glass carrier or a polymer material carrier.Type: GrantFiled: July 4, 2012Date of Patent: March 22, 2016Assignee: Koninklijke Philips N.V.Inventors: Menno Willem Jose Prins, Mikhail Mikhaylovich Ovsyanko, Freek Van Hemert, Arie Rombertus Van Doorn
-
Patent number: 9279802Abstract: A cell sorter including a well that has a microspace filled with a liquid and having a typical length of 1 mm or less, and that has a bottom surface made of a light-permeable material allowing optical observation of an interior of the microspace; a matrix provided on the bottom surface in the well; a bone fragment placed on the matrix in the well; and osteoclasts placed between the matrix and the bone fragment.Type: GrantFiled: August 16, 2012Date of Patent: March 8, 2016Assignees: SHIMADZU CORPORATION, KYOTO UNIVERSITYInventors: Tatsuya Munaka, Hirohisa Abe, Masaki Kanai, Taira Maekawa, Shinya Kimura, Eishi Ashihara
-
Patent number: 9234177Abstract: The invention provides a plurality of embryonic stem cell-like progenitor cells, which are isolated from a human tissue by a systemic screening of human mesenchymal stromal stem/progenitor cells and a cell sorting by a cell antigen selected from the group consisting of CD34, CD117, CD133, CD201, GloboH and combination thereof, and cultured in a medium supplemented with at least one or more steroids and one or more growth factors. The cells of the invention express CD34 and exhibit sphere-like clonogenicity in early passages and express multipotent embryonic stem cells (ESCs) like characteristics.Type: GrantFiled: October 18, 2011Date of Patent: January 12, 2016Assignee: SUNSHINE LIFE SCIENCE & TECHNOLOGY CORP.Inventors: Daniel Tzu-Bi Shih, Ming-Song Tsai
-
Patent number: 9222074Abstract: The invention provides a process for producing a three-dimensional tissue by cultivating eucaryotic cells by introducing the cells into a matrix and cultivating the cells within the matrix in a cell culture medium within a cell culture vessel under controlled dissolved oxygen conditions of the cell culture medium. The matrix contains a support containing an optical oxygen sensor, which is an oxygen-sensitive dye, which upon irradiation with an excitation wavelength changes its emission characteristics in dependence on the dissolved oxygen concentration in the surrounding medium, including a dye phosphorescing upon irradiation of an excitation wavelength, which phosphorescence is quenched by dissolved oxygen.Type: GrantFiled: October 4, 2011Date of Patent: December 29, 2015Assignees: Medizinische Hochschule Hannover, Biomimetics Technologies, Inc.Inventors: Meir Israelowitz, Birgit Weyand, Peter Vogt, Kerstin Reimers, Herbert von Schroeder, Christoph Gille, Elmar Schmaelzlin
-
Patent number: 9162287Abstract: The present invention provides a method for producing gold nanoparticles using hydroxyl peroxide in an aqueous alkaline condition in the presence of a biocompatible protecting agent. The method of the invention does not involve toxic reagents and therefore are environmentally friendly. The gold nanoparticles thus produced can be used in biomedical applications including cancer therapy and drug delivery without purification.Type: GrantFiled: December 21, 2011Date of Patent: October 20, 2015Assignee: NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Masaki Ujihara, Toyoko Imae
-
Patent number: 9145578Abstract: This invention provides a method for separately or simultaneously quantifying cholesterol in a total amount of HDL-C, cholesterol in an HDL subfraction of apoE-containing HDL-C, and cholesterol in an HDL subfraction of apoE-deficient HDL-C. The method comprises enzymatically and separately quantifying cholesterol in apoE-containing HDL and cholesterol in apoE-deficient HDL by adding a surfactant selected from the group consisting of a surfactant with an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of 0.7 to less than 1.3, a surfactant with an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of less than 0.7, and a surfactant with an apoE-containing HDL response rate/apoE-deficient HDL response rate ratio of 1.3 or more to a test sample, allowing cholesterol esterase and cholesterol oxidase to react therewith, and quantifying the hydrogen peroxide generated.Type: GrantFiled: October 26, 2010Date of Patent: September 29, 2015Assignees: Denka Seiken Co., Ltd., National University Corporation Hokkaido UniversityInventors: Yasuki Itoh, Hitoshi Chiba
-
Patent number: 9133424Abstract: Methods for use of select organic compounds for the activation and stabilization of thermally labile enzymes, including proteases, are disclosed. The invention further relates to compositions of certain organic compounds with enzymes to enable the use of such enzymes at high temperature conditions, such as for warewash temperatures and conditions. In particular, organic activator-stabilizers including heat-deactivated proteases and zwitterionic materials are combined with enzymes according to the invention. As a result, the invention provides enzyme cleaning efficacy for various high temperature conditions, including warewash applications.Type: GrantFiled: December 16, 2011Date of Patent: September 15, 2015Assignee: Ecolab USA Inc.Inventors: Kim R. Smith, Thomas R. Mohs
-
Patent number: 9127270Abstract: This invention provides a cell pattern recovery tool comprising a base material layer having a surface subjected to easy adhesion treatment, a temperature responsive polymer layer that is provided on the base material layer and has a surface subjected to silane treatment, and a cell adhesion inhibiting material layer provided on the temperature responsive polymer layer. According to the present invention, a cell pattern can be rapidly recovered while maintaining the cell pattern stably and reliably under minimally invasive conditions for the cells.Type: GrantFiled: August 11, 2009Date of Patent: September 8, 2015Assignees: TOKYO WOMEN'S MEDICAL UNIVERSITY, DAI NIPPON PRINTING CO., LTD.Inventors: Teruo Okano, Masayuki Yamato, Tatsuya Shimizu, Masatoshi Kuroda
-
Patent number: 9128097Abstract: The present invention provides simple, rapid methods and procedures for analyzing cells, hereunder quantitative and qualitative assessment of cells, such as viability. The present invention relates to the use of various optionally substituted reporter compounds particularly detectable upon their reaction with thiol-containing species present in higher concentrations in intact (e.g., living) cells than in non-intact (e.g., dead, stressed and apoptotic) cells. The present invention also relates to the use of various optionally substituted reporter compounds particularly detectable upon their reaction with species present in intact and/or non-intact cells. Moreover, the present invention relates to the use of measuring techniques and/or instruments coupled with the use of various optionally substituted reporter compounds. The invention further relates to compositions used in methods for analyzing cells, such as a composition comprising N-(7-dimethylamino-4-methyl-3-coumarinyl)-maleimide (DACM).Type: GrantFiled: July 13, 2009Date of Patent: September 8, 2015Assignee: ChemoMetec A/SInventors: Mette Elena Skindersø, Helle Frobøse Sørensen, Søren Kjærulff
-
Patent number: 9109221Abstract: Semi-permeable particle can be used to facilitate chemical reactions such as catalytic reactions. The semi-permeable particles are permeable to molecules having a molar mass of 1000 Daltons or less and have a mode particle size of at least 1 ?m. The semi-permeable particles have multiple discrete cavities containing an aqueous solution or suspension of an organic catalytic material. The semi-permeable particles are also impermeable to the organic catalytic materials so they are retained within the multiple discrete cavities, and the semi-permeable particles can be reused multiple times for the same or different chemical reaction.Type: GrantFiled: November 28, 2012Date of Patent: August 18, 2015Assignee: EASTMAN KODAK COMPANYInventors: Mark R. Mis, Mridula Nair, Douglas R. Robello
-
Patent number: 9089550Abstract: An object of the present invention is to provide a pancreatic islet transplantation technique that enables increase of graft survival rate of pancreatic islets after pancreatic islet transplantation, to maintain survival of pancreatic islets, and to reduce the number of transplanted pancreatic islets required for normalizing blood glucose level. When performing pancreatic islet transplantation, by transplanting pancreatic islets and adipose tissue-derived stem cells together, it is possible to significantly improve graft survival rate of transplanted pancreatic islets, and reduce by half the number of transplanted pancreatic islets required for normalizing blood glucose level.Type: GrantFiled: August 5, 2011Date of Patent: July 28, 2015Assignee: OSAKA UNIVERSITYInventors: Masahiro Tanemura, Yoshiaki Omura, Hiroaki Nagano, Masaki Mori, Yuichiro Doki, Toshinori Ito
-
Patent number: 9068166Abstract: Use of a compound of Formula 1 for inducing differentiation of mesenchymal stem cells to chondrocytes, and a pharmaceutical composition for treating a cartilage disease, which includes chondrocytes in which differentiation from mesenchymal stem cells is induced by the compound of Formula 1, are provided. Differentiation of the mesenchymal stem cells treated with the compound of Formula 1 to chondrocytes is specifically induced, and thus the compound can be used to effectively treat a cartilage disease such as arthritis, cartilage damage, and a cartilage defect.Type: GrantFiled: September 16, 2011Date of Patent: June 30, 2015Assignee: Industry-Academic Cooperation Foundation Yonsei UniversityInventors: Ki Chul Hwang, Yang Soo Jang, Gyoon Hee Han
-
Patent number: 9012135Abstract: Provided is a nucleic acid preservative comprising at least one reducing agent, at least one chaotropic substance, at least one polyamine substance and at least one chelating agent and uses thereof, and a method for the preservation of nucleic acids in a biological sample. Further provided are kits for use in the preservation of nucleic acids in a biological sample, and more particularly, a blood sample.Type: GrantFiled: June 15, 2012Date of Patent: April 21, 2015Assignee: Norgen Biotek CorporationInventor: Yousef Haj-Ahmad